Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gout | 26 | 2024 | 614 | 6.520 |
Why?
|
| Uric Acid | 13 | 2024 | 803 | 2.720 |
Why?
|
| Hyperuricemia | 7 | 2022 | 220 | 2.040 |
Why?
|
| Gout Suppressants | 7 | 2024 | 178 | 1.300 |
Why?
|
| Sulfonylurea Compounds | 2 | 2024 | 221 | 1.030 |
Why?
|
| Allopurinol | 4 | 2022 | 200 | 1.010 |
Why?
|
| Efficiency | 2 | 2019 | 477 | 0.970 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2023 | 2160 | 0.950 |
Why?
|
| Clinical Coding | 3 | 2015 | 181 | 0.950 |
Why?
|
| Antirheumatic Agents | 4 | 2023 | 1372 | 0.890 |
Why?
|
| Rheumatic Diseases | 3 | 2021 | 639 | 0.830 |
Why?
|
| Biological Products | 2 | 2020 | 914 | 0.710 |
Why?
|
| Colchicine | 2 | 2021 | 261 | 0.700 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2024 | 329 | 0.690 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2024 | 2286 | 0.680 |
Why?
|
| British Columbia | 8 | 2024 | 239 | 0.670 |
Why?
|
| Health Occupations | 1 | 2020 | 222 | 0.650 |
Why?
|
| Sjogren's Syndrome | 1 | 2019 | 235 | 0.560 |
Why?
|
| Metformin | 1 | 2024 | 912 | 0.540 |
Why?
|
| Absenteeism | 1 | 2017 | 250 | 0.530 |
Why?
|
| Databases, Factual | 7 | 2024 | 8000 | 0.520 |
Why?
|
| Hypoglycemic Agents | 4 | 2024 | 3150 | 0.510 |
Why?
|
| Hospitalization | 9 | 2024 | 10734 | 0.510 |
Why?
|
| Autoimmune Diseases | 2 | 2017 | 2250 | 0.490 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 11888 | 0.490 |
Why?
|
| Scleroderma, Systemic | 1 | 2019 | 344 | 0.490 |
Why?
|
| Commerce | 1 | 2020 | 604 | 0.470 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 865 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 12268 | 0.460 |
Why?
|
| Primary Prevention | 1 | 2020 | 1203 | 0.420 |
Why?
|
| International Classification of Diseases | 2 | 2015 | 882 | 0.400 |
Why?
|
| Medicaid | 2 | 2021 | 2808 | 0.340 |
Why?
|
| Insulin Resistance | 2 | 2021 | 3959 | 0.310 |
Why?
|
| Population Surveillance | 1 | 2019 | 2609 | 0.300 |
Why?
|
| Stroke | 2 | 2023 | 9935 | 0.290 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 7790 | 0.290 |
Why?
|
| Health Expenditures | 1 | 2020 | 2359 | 0.280 |
Why?
|
| Health Surveys | 1 | 2017 | 4060 | 0.280 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 1266 | 0.280 |
Why?
|
| Diuretics | 2 | 2020 | 612 | 0.280 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2019 | 3762 | 0.280 |
Why?
|
| Health Care Costs | 1 | 2019 | 3255 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3438 | 0.260 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5500 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 15750 | 0.250 |
Why?
|
| Medicare | 2 | 2021 | 6763 | 0.240 |
Why?
|
| Diet, Mediterranean | 2 | 2022 | 732 | 0.230 |
Why?
|
| Humans | 47 | 2024 | 759255 | 0.230 |
Why?
|
| Death Certificates | 2 | 2015 | 167 | 0.230 |
Why?
|
| Middle Aged | 25 | 2024 | 219653 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 17750 | 0.220 |
Why?
|
| Nutrition Surveys | 4 | 2023 | 1721 | 0.210 |
Why?
|
| Cohort Studies | 9 | 2024 | 41247 | 0.200 |
Why?
|
| Recurrence | 2 | 2024 | 8469 | 0.190 |
Why?
|
| Obesity | 6 | 2021 | 12896 | 0.190 |
Why?
|
| Aged | 20 | 2024 | 168617 | 0.190 |
Why?
|
| Canada | 2 | 2024 | 2124 | 0.190 |
Why?
|
| Male | 26 | 2024 | 358719 | 0.180 |
Why?
|
| Hydroxychloroquine | 2 | 2023 | 428 | 0.180 |
Why?
|
| Female | 29 | 2024 | 390240 | 0.180 |
Why?
|
| Incidence | 6 | 2022 | 21336 | 0.180 |
Why?
|
| Prevalence | 6 | 2023 | 15641 | 0.180 |
Why?
|
| Health Status Disparities | 2 | 2023 | 1819 | 0.170 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2023 | 987 | 0.170 |
Why?
|
| Risk Factors | 12 | 2023 | 74167 | 0.170 |
Why?
|
| Adult | 18 | 2024 | 219390 | 0.160 |
Why?
|
| Arthralgia | 1 | 2022 | 461 | 0.160 |
Why?
|
| Sodium | 1 | 2023 | 1601 | 0.150 |
Why?
|
| Depression | 1 | 2017 | 8026 | 0.150 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 330 | 0.150 |
Why?
|
| San Francisco | 1 | 2017 | 161 | 0.150 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2020 | 261 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 39216 | 0.140 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 4006 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2021 | 760 | 0.140 |
Why?
|
| Prescriptions | 1 | 2019 | 388 | 0.140 |
Why?
|
| Retinal Diseases | 1 | 2023 | 702 | 0.140 |
Why?
|
| Propensity Score | 1 | 2024 | 1915 | 0.140 |
Why?
|
| Drug Eruptions | 1 | 2019 | 335 | 0.130 |
Why?
|
| Drugs, Generic | 1 | 2021 | 448 | 0.130 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 25860 | 0.120 |
Why?
|
| Body Mass Index | 3 | 2021 | 12874 | 0.120 |
Why?
|
| Heart Failure | 2 | 2019 | 11833 | 0.120 |
Why?
|
| Drug Approval | 1 | 2021 | 815 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2023 | 54204 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1676 | 0.100 |
Why?
|
| Life Style | 2 | 2021 | 3886 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2021 | 2617 | 0.100 |
Why?
|
| Hypertension | 3 | 2021 | 8594 | 0.100 |
Why?
|
| Adiposity | 1 | 2021 | 1848 | 0.100 |
Why?
|
| Glucose | 1 | 2023 | 4361 | 0.100 |
Why?
|
| Workplace | 1 | 2017 | 854 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2017 | 977 | 0.090 |
Why?
|
| Vaccines | 1 | 2019 | 833 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2020 | 1293 | 0.090 |
Why?
|
| Risk Assessment | 5 | 2024 | 24049 | 0.090 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 1849 | 0.090 |
Why?
|
| Social Class | 1 | 2019 | 2005 | 0.090 |
Why?
|
| Glucocorticoids | 2 | 2016 | 2142 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1588 | 0.090 |
Why?
|
| Educational Status | 1 | 2017 | 2511 | 0.090 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 15728 | 0.090 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 899 | 0.090 |
Why?
|
| United States | 7 | 2023 | 72237 | 0.080 |
Why?
|
| Self Report | 1 | 2020 | 3699 | 0.080 |
Why?
|
| Income | 1 | 2017 | 1876 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 2161 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 1498 | 0.080 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2015 | 1032 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 3368 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 5058 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2017 | 1936 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3152 | 0.070 |
Why?
|
| Vaccination | 1 | 2019 | 3354 | 0.070 |
Why?
|
| Insulin | 1 | 2021 | 6591 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 2536 | 0.070 |
Why?
|
| Diet | 5 | 2023 | 8002 | 0.070 |
Why?
|
| Poverty | 1 | 2017 | 2682 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 5880 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2024 | 80121 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2659 | 0.060 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2024 | 98 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7788 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21988 | 0.060 |
Why?
|
| Mental Health | 1 | 2017 | 3195 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14442 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2017 | 4428 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3207 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4680 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 6168 | 0.050 |
Why?
|
| Comorbidity | 3 | 2021 | 10547 | 0.050 |
Why?
|
| Smoking | 1 | 2017 | 9066 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 281 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14652 | 0.040 |
Why?
|
| Israel | 1 | 2020 | 721 | 0.040 |
Why?
|
| Nutrition Policy | 1 | 2022 | 470 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12522 | 0.040 |
Why?
|
| Sulfinpyrazone | 1 | 2016 | 15 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2020 | 487 | 0.040 |
Why?
|
| Uricosuric Agents | 1 | 2016 | 32 | 0.030 |
Why?
|
| Probenecid | 1 | 2016 | 75 | 0.030 |
Why?
|
| Population Growth | 1 | 2016 | 50 | 0.030 |
Why?
|
| Sex Factors | 2 | 2021 | 10518 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2017 | 507 | 0.030 |
Why?
|
| Young Adult | 3 | 2021 | 58483 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2023 | 2203 | 0.030 |
Why?
|
| Fruit | 1 | 2021 | 1162 | 0.030 |
Why?
|
| Vegetables | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2024 | 64879 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2020 | 2294 | 0.030 |
Why?
|
| Age Distribution | 1 | 2020 | 2892 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2016 | 1155 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2058 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Reference Values | 1 | 2020 | 4918 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 13238 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15815 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 782 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3721 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29561 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2616 | 0.020 |
Why?
|
| Time Factors | 2 | 2021 | 40109 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58867 | 0.020 |
Why?
|
| Weight Loss | 1 | 2020 | 2673 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9711 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1935 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2420 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3731 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10185 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10827 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5876 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12152 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.020 |
Why?
|
| Inflammation | 1 | 2024 | 10747 | 0.010 |
Why?
|
| Logistic Models | 1 | 2019 | 13309 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18394 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 87560 | 0.010 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_